![Nathalie Trépo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nathalie Trépo active positions
Companies | Position | Start | End |
---|---|---|---|
SparingVision SAS
![]() SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Investor Relations Contact | 31/01/2022 | - |
Public Communications Contact | 31/01/2022 | - |
Career history of Nathalie Trépo
Statistics
International
France | 4 |
Operational
Investor Relations Contact | 3 |
Public Communications Contact | 1 |
Sectoral
Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
NEOVACS | Health Technology |
Private companies | 2 |
---|---|
Theradiag SA
![]() Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France. | Health Technology |
SparingVision SAS
![]() SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Nathalie Trépo
- Experience